Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I bet you are about to get a real education in public market biotech today. There is no data, and the only thing you can count on is a money raise in the low $1.10 range.
Been waiting almost 6 years for any reason to re-enter my $6.50+ exit.
There is none.
Market makers have been loading up all pre market! Looking good!
Hope everyone had a good fourth and we have a good day today :D
News will spread over the long weekend.
Time to start going up skipping cents along the way
MARKET MAKERS HAVE BEEN LOADING GET READY FOR NEXT LEG UP
A 20 cent jump would be nothing compared to what it can do from this price.
WOW!! This is an exciting Board!! That's for sure!!! But, TCRT is up by 7% 'After Hours', as I speak!! Might have a monster run-up Monday???? RIGHT???????
UVSS bb stocks latest throbber hes been in for a year
keep track of TA
notice why SMCE cant run? like a 400m share increase in 3 months
the toothless meth addicted ones
im long on ATAO, 10m shares only added to OS in 3 months is minimal as it get, lithium with SXOOF 60% interest connections
Yup! Dirty strippers
nice to hear from you buddy, markets play like a dirty sanchez
so many red candles, new symbol same stock
https://www.stockscores.com/chart.asp?TickerSymbol=%20ziop&TimeRange=365&Interval=w&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=100&Indicator1=AccDist&Indicator2=StochRSI&Indicator3=CMF&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen
so many red candles, new symbol same stock
https://www.stockscores.com/chart.asp?TickerSymbol=%20ziop&TimeRange=365&Interval=w&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=100&Indicator1=AccDist&Indicator2=StochRSI&Indicator3=CMF&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen
NEW TICKER SYMBOL.........just yesterday they announced re-brand , and moving to texas.....trials M D ANDERSON
sounds like a buy-out announcement is in the near future
$$$$$$$$$$$$ ALAUNOS $$$$$$$$$$$$$$$$$...gl
Re: Ziopharm Oncology Highlights Operational Progress & Rebrands to Alaunos Therapeutics
New symbol
TCRT
effective tomorrow at open
have not been in this for a while......dropped off a cliff with about 5 mins left.......bought a pretty good pile of 94`s and 95`s
insider buying in the fourth qtr.
$$$$$$$$$$$$$$$$$$$ ZIOPHARM $$$$$$$$$$$$$$$....gla
hu hi @dirty ,confirm completly, chart 2010 simply to read. Always same procedure. Insiders bougt shares- in Bottom 1,60 - but not sure abt next target to sell? May you look to NXO.v just startin with their new optical patents. ZiOP long term Chart is periodical up to 2,25 - 2,90 - 3,73 - so far re charting.
Last - 5 Insiders bought shares inSeptember. SEC Filings. Anyone idea right point to sell ? Hold several stocks in CAD and US. HD.
agree on 10 bagger......been buggin me on high price!........just checked a trading log from 2015.......i see flipping this a lot in the $12-$14 range back then
$$$$$$$$$$$$$$$$$$$$ ZIOPHARM $$$$$$$$$$$$$$$$$$$$$$
used to ..buy sell short and cover this many times daily back about 2016...2017......still have a core thats about 3 years old......good to see this moving again...played it alot when it was trading about $7....mgmt from Xon f`d this up for a while.....and kirk took out quite a bit of its value
he`s long gone......time for ZIOPHARM to shine once again...gla
$$$$$$$$$$$$$$$$$$$$ ZIOP $$$$$$$$$$$$$$$$$$$$
A great trading day for a smart company with nimble trades and keep a piece in your pocket for the long term break out play. 10 bagger in the making
If the market can pull its shit together this will do real well tomorrow
Hope you are still enjoying this as much as i am. Check out RGLS also, good data so far and end of Q1 should be lift off!
Blackrock increased ownership
Oncology stocks are on the move my picks are:
1.ZIOP 800 million market cap chart looks good. Gene editing play.
2.PDSB 60 million market cap chart looks great CD8+ (killer) T-cells.
$ZIOP
Company managed to successfully convince one of the large investors to change their nay vote. All items passed with the exception of the issuance of additional shares. Apparently the concession for changing their vote was to make the point the company must produce before they get access to any additional funds. No more dilutive financing without results. Minor victory, but largely disappointed.
It appears that the Company does not have the shareholder votes to re-elect the Board of Directors nor approve the ridiculous compensation management is getting. We will know tomorrow (if not postponed). I hope all proposals fail. Cooper is not CEO material, not even senior manager level of any kind. Never invest in a biotech with an MD at the helm, never; no matter how promising. So many clinical deadlines have passed, so many promises broken, no urgency to get things done; no fiduciary sense of any kind, no shareholder accountability. All this without a modicum of explanation of any kind to the shareholders. The ridiculous secondary of four months ago was the last straw, literally conceding to shorts by allowing them to `invest' and cover. . . . the same people who have tried to bankrupt this company for the last five years.
The company may take a $$ hit on this but will ultimately be placed in more competent hands; we can not get any worse decision making than present. We have no idea after five years of what, if any, of this `ground breaking' technology clinically works. Clearly there are issues with the NCI. Programs invested in five years ago just drop off the company radar with no comment by management. Worst company I have ever encountered. Millions of bonuses and compensation to Cooper over the years and he has not once bought a single share in this company; just the recipient of endless gifts. Complete disgrace. Don't want him as CMO either. Carl June to the rescue please.
Clearly Cooper deserves another bonus, talent like his is hard to come by.
5 years as CEO - nothing accomplished/achieved. Everything delayed yet again; this time, saved by the virus. First three years was the conflict with Kirk. First dosing of a patient rumored to be any decade now.
Just one shot left on goal now from three decent shots outlined five years ago. Any hope now is placed solely on Rosenberg. No longer an investment, merely one roll of the roulette ball. Technology of numerous other biotechs have caught and surpassed us, this is merely a management ATM. Cooper has not bought one share in this company from his own funds.
Wow earning estimates met for this quarter - (21q1)
quiet board....where is everyone....earnings miss, as expected....now at $2.82....this might get interesting soon...glta
waiting patiently for this to drop under $3 for a bounce play.....in and out quickly!.....4 or 5 years ago, this was the "perfect kiddy coaster"...…..buy sell short cover...dozen times a day...….predictable time frames......made truckloads on this......too bad their science didn`t keep up with their competition...…..O S should be well over 225 when this round of dilution ends.....ziop will be otc next year....glta
* * $ZIOP Video Chart 02-10-2020 * *
Link to Video - click here to watch the technical chart video
Thanks
I will check out.
Good move, keep watching. $2's are very possible. Another secondary to dilute shareholders. No progress in last five years. Clinical trial pulled with no management comment. Secondary issued with no management comments. Only one remaining "shot" on goal. Rosenberg NCI trial has still not dosed its first patient. IL-12 looks like a bust after being a primary strategy for years. Other Bio companies making great strides; our heralded Sleeping Beauty delivery system on the verge of being completely antiquated as CEO bumbles around letting timeline after timeline slip. Terrible CEO and probably not CMO caliber either (despite being a self proclaimed genius). Lawrence had MDA roots, I bet they do not miss him.
Still hope for share price improvement of course, but buying it as a lottery ticket should be your financial objective. PROF and AUPH are just two of dozens of better investments if you are looking for clinical stage or recently FDA approved companies. Was a bull on this company for years, now just a bag holder on my remaining few shares.
Thanks for your thought. I appreciate that. I have been just watching for 2 months, thinking to buy some when time is right. I have a lot of patience. Let me know if you think it is good time to get in this stock.
Followers
|
82
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1228
|
Created
|
08/08/06
|
Type
|
Free
|
Moderators |
http://www.ziopharm.com/
http://finance.yahoo.com/q/h?s=ZIOP
ZIOPHARM Oncology, Inc., a biopharmaceutical company, engages in the development and commercialization of a portfolio of in-licensed cancer drugs. It focuses primarily on the licensing and development of proprietary drug candidate families that are related to cancer therapeutics that are already on the market or in development. The company�s product candidates include ZIO-101, ZIO-201, and ZIO-301, which are in phase I and/or II studies. ZIO-101, organic arsenic is in a phase I/II trial in patients with advanced myeloma, as well as a phase I trial in advanced cancers; ZIO-201, stabilized isophosphoramide mustard is in a phase I/II trial in patients with advanced sarcoma, as well as in a phase I trials in advanced cancers; and ZIO-301, an anti-cancer agent that targets mitosis like the taxanes is in a phase I trial. ZIOPHARM was founded in 2003 and is based in New York, New York.
>
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |